FFCP PHASE1:Mm9::chr5:67751606..67751616,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=187|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr5:67751606..67751616,+|id=chr5:67751606..67751616,+|ontology_enrichment_celltype=CL:0000553!3.87e-08!6;CL:0000556!3.87e-08!6;CL:0002031!4.85e-07!25|ontology_enrichment_celltype_v019_2=CL:0000625,3.06e-23,1;CL:0000084,1.00e-18,11;CL:0000827,1.00e-18,11;CL:0000838,2.99e-17,12;CL:0000542,5.32e-16,13;CL:0000051,5.32e-16,13;CL:0000738,1.84e-12,17;CL:0002087,1.84e-12,17;CL:0002031,9.29e-09,25;CL:0000988,5.08e-07,32;CL:0002032,5.08e-07,32;CL:0000037,5.08e-07,32;CL:0000837,5.08e-07,32|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002193!6.95e-09!48;UBERON:0002390!1.20e-07!45;UBERON:0003061!1.20e-07!45|ontology_enrichment_uberon_v019_2=UBERON:0000029,1.39e-22,1;UBERON:0001097,1.39e-22,1;UBERON:0003968,1.39e-22,1;UBERON:0001467,1.39e-22,1;UBERON:0002465,1.88e-08,3|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.404950534779652,0,0.788655413395594,0.274228867211478,0,0,1.98581902401771,3.39559725880616,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7813353445238,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.36921938885203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,1.03575153458869,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0.144649058581512,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.512612642393558,0,0,0.188368457004691,0,0,0.169978429993855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316011120628178,0,0,0,0,0,0,0,0,0,0,0.0974578807397524,0.192423683280659,0.116876902181569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr5:67751606..67751616,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=187 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr5:67751606..67751616,+ | |||
|description=CAGE_peak_at_chr5:67751606..67751616,+ | |||
|id=chr5:67751606..67751616,+ | |||
|ontology_enrichment_celltype=CL:0000553!3.87e-08!6;CL:0000556!3.87e-08!6;CL:0002031!4.85e-07!25 | |||
|ontology_enrichment_celltype_v019_2=CL:0000625,3.06e-23,1;CL:0000084,1.00e-18,11;CL:0000827,1.00e-18,11;CL:0000838,2.99e-17,12;CL:0000542,5.32e-16,13;CL:0000051,5.32e-16,13;CL:0000738,1.84e-12,17;CL:0002087,1.84e-12,17;CL:0002031,9.29e-09,25;CL:0000988,5.08e-07,32;CL:0002032,5.08e-07,32;CL:0000037,5.08e-07,32;CL:0000837,5.08e-07,32 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002193!6.95e-09!48;UBERON:0002390!1.20e-07!45;UBERON:0003061!1.20e-07!45 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000029,1.39e-22,1;UBERON:0001097,1.39e-22,1;UBERON:0003968,1.39e-22,1;UBERON:0001467,1.39e-22,1;UBERON:0002465,1.88e-08,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.404950534779652,0,0.788655413395594,0.274228867211478,0,0,1.98581902401771,3.39559725880616,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7813353445238,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.36921938885203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,1.03575153458869,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0.144649058581512,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.512612642393558,0,0,0.188368457004691,0,0,0.169978429993855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316011120628178,0,0,0,0,0,0,0,0,0,0,0.0974578807397524,0.192423683280659,0.116876902181569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr5:67751606..67751616,+ | |||
}} |
Latest revision as of 13:38, 4 August 2015
Short description: | p@chr5:67751606..67751616, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr5:67751606..67751616, + |
Coexpression cluster: | MCL_coexpression_mm9:187 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
CD8-positive, alpha-beta T cell | 3.06e-23 | 1 |
T cell | 1.00e-18 | 11 |
pro-T cell | 1.00e-18 | 11 |
lymphoid lineage restricted progenitor cell | 2.99e-17 | 12 |
lymphocyte | 5.32e-16 | 13 |
common lymphoid progenitor | 5.32e-16 | 13 |
leukocyte | 1.84e-12 | 17 |
nongranular leukocyte | 1.84e-12 | 17 |
hematopoietic lineage restricted progenitor cell | 9.29e-09 | 25 |
hematopoietic cell | 5.08e-07 | 32 |
hematopoietic oligopotent progenitor cell | 5.08e-07 | 32 |
hematopoietic stem cell | 5.08e-07 | 32 |
hematopoietic multipotent progenitor cell | 5.08e-07 | 32 |
Ontology term | p-value | n |
---|---|---|
lymph node | 1.39e-22 | 1 |
axillary lymph node | 1.39e-22 | 1 |
peripheral lymph node | 1.39e-22 | 1 |
shoulder | 1.39e-22 | 1 |
lymphoid system | 1.88e-08 | 3 |